Invesaro

Stocks Comparison

National Vision vs Staar Surgical: revenue, profit, margins and growth compared

National Vision brought in $2B of revenue in fiscal 2025, Staar Surgical $239.4M in fiscal 2025. Revenue changed by +9.0% at National Vision and -23.7% at Staar Surgical on the year before, so National Vision grew faster. National Vision kept 1.5% of its revenue as net profit, Staar Surgical -33.6%. Free cash flow was $73.5M at National Vision and -$40.1M at Staar Surgical.

Side by side, latest fiscal year

EYESTAA
Fiscal year endedFY2025 (January 3, 2026)FY2025 (January 2, 2026)
Revenue$2B$239.4M
Revenue growth+9.0%-23.7%
Net income$29.6M-$80.4M
Net margin1.5%-33.6%
Free cash flow$73.5M-$40.1M
Free cash flow margin3.7%-16.7%
Earnings per share (diluted)$0.37-$1.62
Cash$38.7M$153.2M
Debt$236.5Mn/a
Price to earnings44.7n/a
Market value$1.3B$1B
Dividend yieldn/an/a
Rank by revenue in sector#110 of 523 · Health care#239 of 523 · Health care

Over the years

Revenue
EYE FY2018: $1.5BEYE FY2019: $1.7BEYE FY2020: $1.7BEYE FY2021: $2.1BEYE FY2022: $1.6BEYE FY2023: $1.8BEYE FY2024: $1.8BEYE FY2025: $2BSTAA FY2018: $124MSTAA FY2019: $150.2MSTAA FY2020: $163.5MSTAA FY2021: $230.5MSTAA FY2022: $239.4MSTAA FY2023: $322.4MSTAA FY2024: $313.9MSTAA FY2025: $239.4MFY18FY19FY20FY21FY22FY23FY24FY25
EYE $2BSTAA $239.4M
Net income
EYE FY2018: $23.7MEYE FY2019: $32.8MEYE FY2020: $36.3MEYE FY2021: $128.2MEYE FY2022: $42.1MEYE FY2023: -$65.9MEYE FY2024: -$28.5MEYE FY2025: $29.6MSTAA FY2018: $5MSTAA FY2019: $14MSTAA FY2020: $5.9MSTAA FY2021: $27.5MSTAA FY2022: $39.7MSTAA FY2023: $21.3MSTAA FY2024: -$20.2MSTAA FY2025: -$80.4MFY18FY19FY20FY21FY22FY23FY24FY25
EYE $29.6MSTAA -$80.4M
Net margin
EYE FY2018: 1.5%EYE FY2019: 1.9%EYE FY2020: 2.1%EYE FY2021: 6.2%EYE FY2022: 2.6%EYE FY2023: -3.8%EYE FY2024: -1.6%EYE FY2025: 1.5%STAA FY2018: 4.0%STAA FY2019: 9.4%STAA FY2020: 3.6%STAA FY2021: 11.9%STAA FY2022: 16.6%STAA FY2023: 6.6%STAA FY2024: -6.4%STAA FY2025: -33.6%FY18FY19FY20FY21FY22FY23FY24FY25
EYE 1.5%STAA -33.6%
Revenue growth
EYE FY2019: +12.2%EYE FY2020: -0.7%EYE FY2021: +21.5%EYE FY2022: -20.9%EYE FY2023: +6.8%EYE FY2024: +3.8%EYE FY2025: +9.0%STAA FY2019: +21.2%STAA FY2020: +8.8%STAA FY2021: +41.0%STAA FY2022: +3.9%STAA FY2023: +34.7%STAA FY2024: -2.6%STAA FY2025: -23.7%FY19FY20FY21FY22FY23FY24FY25
EYE +9.0%STAA -23.7%
Free cash flow
EYE FY2018: $2.1MEYE FY2019: $63.8MEYE FY2020: $158.2MEYE FY2021: $163.4MEYE FY2022: $5.7MEYE FY2023: $58.3MEYE FY2024: $38.1MEYE FY2025: $73.5MSTAA FY2018: $10.5MSTAA FY2019: $15.7MSTAA FY2020: $12.5MSTAA FY2021: $30.3MSTAA FY2022: $17.6MSTAA FY2023: -$3.6MSTAA FY2024: -$7.7MSTAA FY2025: -$40.1MFY18FY19FY20FY21FY22FY23FY24FY25
EYE $73.5MSTAA -$40.1M

Fiscal years as each company reports them; the two may end in different months.

Questions about National Vision and Staar Surgical

Which is bigger by revenue, National Vision or Staar Surgical?

National Vision is bigger by revenue: $2B in fiscal 2025, against $239.4M for Staar Surgical in fiscal 2025.

Which keeps more of its revenue as profit, National Vision or Staar Surgical?

National Vision had a net margin of 1.5% in fiscal 2025; Staar Surgical had -33.6% in fiscal 2025.

Which grew revenue faster, National Vision or Staar Surgical?

In their latest fiscal years revenue changed by +9.0% at National Vision and -23.7% at Staar Surgical.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies